JAM2 Human

Junctional Adhesion Molecule 2 Human Recombinant
Cat. No.
BT17019
Source
Escherichia Coli.
Synonyms
Junctional adhesion molecule B, JAM-B, Junctional adhesion molecule 2, JAM-2, Vascular endothelial junction-associated molecule, VE-JAM, CD322.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

JAM2 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 241 amino acids (21-238) and having a molecular mass of 26.7kDa.
JAM2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Junctional Adhesion Molecule 2 (JAM2) belongs to the immunoglobulin superfamily and the junctional adhesion molecule (JAM) family. This type I membrane protein resides at the tight junctions of both epithelial and endothelial cells. JAM2 acts as an adhesive ligand, facilitating interactions with various immune cells, and potentially playing a role in lymphocyte homing to secondary lymphoid organs.
Description
Recombinant human JAM2, produced in E.coli, is a single, non-glycosylated polypeptide chain. It comprises 241 amino acids (21-238) and has a molecular weight of 26.7kDa. JAM2 is fused to a 23 amino acid His-tag at its N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
Colorless solution, sterile filtered.
Formulation
JAM2 protein solution at a concentration of 1mg/ml. The solution contains 20mM Tris-HCl buffer (pH 8.0), 0.4M urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), store at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 90.0% as determined by SDS-PAGE analysis.
Synonyms
Junctional adhesion molecule B, JAM-B, Junctional adhesion molecule 2, JAM-2, Vascular endothelial junction-associated molecule, VE-JAM, CD322.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSLGYHKAY GFSAPKDQQV VTAVEYQEAI LACKTPKKTV SSRLEWKKLG RSVSFVYYQQ TLQGDFKNRA EMIDFNIRIK NVTRSDAGKY RCEVSAPSEQ GQNLEEDTVT LEVLVAPAVP SCEVPSSALS GTVVELRCQD KEGNPAPEYT WFKDGIRLLE NPRLGSQSTN SSYTMNTKTG TLQFNTVSKL DTGEYSCEAR NSVGYRRCPG KRMQVDDLNI S.

Product Science Overview

Introduction

Junctional Adhesion Molecule 2 (JAM2) is a member of the immunoglobulin superfamily and is primarily localized at the tight junctions of both epithelial and endothelial cells . It plays a crucial role in cell adhesion, migration, and maintaining the integrity of cell junctions . The recombinant form of JAM2, often referred to as “Human Recombinant JAM2,” is utilized in various research and therapeutic applications.

Structure and Function

JAM2 is a type I membrane protein that consists of an extracellular domain, a single transmembrane region, and a cytoplasmic tail . The extracellular domain is responsible for mediating homophilic (JAM2-JAM2) and heterophilic (JAM2-other proteins) interactions . These interactions are vital for the assembly and maintenance of tight junctions, which regulate paracellular permeability and maintain cell polarity .

Role in Cell Migration and Adhesion

JAM2 is involved in various cellular processes, including cell migration and adhesion . It acts as an adhesive ligand for interacting with a variety of immune cell types, such as leukocytes, and plays a role in lymphocyte homing to secondary lymphoid organs . JAM2’s interaction with other proteins, such as PDZ domain-containing scaffolding proteins, regulates cell-cell contact maturation and the generation of junctional complexes .

Expression and Regulation

The expression of JAM2 is regulated by several factors, including hormones and cytokines . For instance, progesterone and leukemia inhibitory factor (LIF) have been shown to up-regulate JAM2 expression in the uterine luminal epithelium, which is crucial for blastocyst adhesion during early pregnancy . This regulation is mediated through the tyrosine phosphorylation of Stat3 .

Clinical and Research Applications

Human Recombinant JAM2 is widely used in research to study its role in various physiological and pathological processes. It is also being explored for therapeutic applications, particularly in the context of inflammation, cancer, and reproductive health . The recombinant form allows for controlled studies and potential therapeutic interventions by mimicking the natural protein’s function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.